MBS8400222 | Anti-alpha4beta7 Integrin (Vedolizumab); Humanized Antibody

Anti-alpha4beta7 Integrin (Vedolizumab); Humanized Antibody | MBS8400222 | Mybiosource

Product Short Name: [alpha4beta7 Integrin]

Product Name Synonyme: [LDP 02; LDP-02; LDP02; MLN-0002; MLN-02; MLN0002; MLN02; ENTYVIO; alpha4beta7; ITGA4/ITGB7]

Other Names: N/A

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: IgG1; kappa

Clone: N/A

Host: Human

Reactivity: Human

Specificity: Vedolizumab is a humanized monoclonal antibody that binds to alpha4beta7 integrin expressed on the surface of T and B lymphocytes and prevents gastrointestinal inflammatory activity. The monoclonal antibody received approval from the FDA for the treatment ofulcerative colitis and Crohn's disease

Purity: Protein A purified

Form: Colorless liquid. In PBS; pH7.5

Concentration: 1mg/ml

Storage Stability: Store at -80 degree C. The antibody solution should be gently mixed before use.
Shipping: Gel Pack
Shelf Life: Est.~12 months
Country of Origin: USA

Tested Application: N/A